(EMSRI) Amundi Index MSCI Emerging - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Etf • ISIN: LU1861138961 • Global Emerging Markets Equity

EMSRI: Stocks, Bonds, Emerging Markets, Sustainability, Investments

Amundi Index MSCI Emerging Markets SRI UCITS ETF (EMSRI), listed on Euronext Paris, is a French-originated ETF focusing on global emerging markets equity with an AUM of 1428.34M EUR. As a passively managed fund, it doesnt rely on traditional valuation metrics like P/E or P/B, emphasizing index replication over stock selection.

EMSRI employs a passive investment strategy, tracking the Morningstar EM Total Return Net USD Index. This approach incorporates ESG criteria, aligning with sustainable investing principles. The funds UCITS compliance ensures it meets European regulatory standards, making it accessible to a broad investor base.

The Morningstar index offers extensive coverage of emerging markets, providing diversified exposure across key regions and sectors. Its designed for investors seeking broad market representation beyond traditional indices, with a focus on risk-adjusted returns.

Key considerations for investors include understanding the funds index methodology, the inherent risks of emerging markets, potential tracking difference, and the funds appeal to ESG-focused investors. These factors highlight EMSRIs role in portfolios seeking diversified, ESG-conscious exposure to emerging markets.

Additional Sources for EMSRI ETF

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

EMSRI ETF Overview

Market Cap in USD 1,555m
Category Global Emerging Markets Equity
TER 0.25%
IPO / Inception 2019-01-16

EMSRI ETF Ratings

Growth 5y 32.7%
Fundamental -
Dividend 0.0%
Rel. Strength Industry -1.08
Analysts -
Fair Price Momentum 46.28 EUR
Fair Price DCF -

EMSRI Dividends

No Dividends Paid

EMSRI Growth Ratios

Growth Correlation 3m -6.4%
Growth Correlation 12m 81.1%
Growth Correlation 5y -3.3%
CAGR 5y 8.15%
CAGR/Max DD 5y 0.32
Sharpe Ratio 12m 0.75
Alpha -0.59
Beta 0.63
Volatility 21.00%
Current Volume 5k
Average Volume 20d 4.2k
What is the price of EMSRI stocks?
As of March 14, 2025, the stock is trading at EUR 50.90 with a total of 4,995 shares traded.
Over the past week, the price has changed by -2.02%, over one month by -6.82%, over three months by -6.65% and over the past year by +5.29%.
Is Amundi Index MSCI Emerging a good stock to buy?
Neither. Based on ValueRay Analyses, Amundi Index MSCI Emerging is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 32.70 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMSRI as of March 2025 is 46.28. This means that EMSRI is currently overvalued and has a potential downside of -9.08%.
Is EMSRI a buy, sell or hold?
Amundi Index MSCI Emerging has no consensus analysts rating.
What are the forecast for EMSRI stock price target?
According to ValueRays Forecast Model, EMSRI Amundi Index MSCI Emerging will be worth about 51.3 in March 2026. The stock is currently trading at 50.90. This means that the stock has a potential upside of +0.71%.
Issuer Forecast Upside
Wallstreet Target Price - -
Analysts Target Price - -
ValueRay Target Price 51.3 0.7%